Updates are available Correction dated 2021-06-30
Click to view Correction: https://doi.org/10.1038/s41565-021-00937-w
-
Authors
Kulkarni, Jayesh A. https://orcid.org/0000-0002-3622-6998
Witzigmann, Dominik https://orcid.org/0000-0002-8197-8558
Thomson, Sarah B. https://orcid.org/0000-0001-9407-1245
Chen, Sam
Leavitt, Blair R. https://orcid.org/0000-0002-4532-766X
Cullis, Pieter R. https://orcid.org/0000-0001-9586-2508
van der Meel, Roy https://orcid.org/0000-0002-2200-7946
-
Funding
Funding for this research was provided by:
NanoMedicines Innovation Network
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (183923)
Huntington Society of Canada
Fondation Brain Canada
Weston Brain Institute
NMIN
Gouvernement du Canada | Canadian Institutes of Health Research (148469)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (016.176.622)
- License Information
-
More Information
Article History
Received: 26 July 2020
Accepted: 11 March 2021
First Online: 31 May 2021
Change Date: 30 June 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41565-021-00937-w
Competing interests
: P.R.C. is a co-founder and shareholder of Acuitas Therapeutics and Precision Nanosystems and Scientific Director and CEO of the NMIN. B.R.L. is a co-founder, shareholder and CEO of Incisive Genetics Inc. The authors declare no other competing financial interests.
